Guest:  Adam Jenkins What actually makes or breaks a biotech startup - and why is it rarely the science? In this episode of Boba & Biotech, Adam Jenkins and I enjoy some delicious grapefruit-coconut sago from Heytea while we discuss the hidden dynamics shaping today’s biotech ecosystem. From the inside workings of incubators like BioLabs and LabCentral to the uncomfortable truth about “zombie” startups, this conversation pulls back the curtain on what really happens between breakthrough science and company success. Along the way, Adam shares hard-earned insights from years of evaluating and advising early-stage companies, revealing why culture trumps data, why your first hires matter more than your pitch deck, and why taking VC money too early might be your biggest mistake. If you’re a founder, operator, or investor navigating biotech, this episode is equal parts reality check and roadmap. Adam Jenkins is the regional site director for BioLabs, where he manages sites across Boston, Cambridge, Vermont, and Toronto. BioLabs is a global innovation infrastructure company creating the physical and community backbone that powers life science discovery worldwide. Prior to BioLabs Adam worked at Biogen, a global biotech focused on neurology, where he headed their data science teams and helped lead their portfolio strategy. He holds a PhD in genetics from Boston College and an MBA from Indiana University. Links Armon’s LinkedIn - https://www.linkedin.com/in/armonsharei/   Adam’s LinkedIn - https://www.linkedin.com/in/adammjenks/ Biolabs: https://www.biolabs.io/  Credits Hosted by Armon Sharei, PhD Research by Julie Kim, MBA Produced by Arielle Nisseblatt of Pinwheel, Andressa Carroll, Portal Edited and mixed by David Woje of Pinwheel